Ergebnisse 1 - 10 von 300 :

  • "testosterone" x
Alle zurücksetzen
Low Total Testosterone-Component of Metabolic Syndrome

R eferences 1. Haller H. Epidermiology and associated risk factors of hyperlipoproteinemia, Z Gesamte Inn Med 32(8): 124–28, 1977 2. Reaven GM . Banting lecture 1988. Role of insulin resistance in human disease". Diabetes 37(12): 1595–607, 1988 3. Travison TG, Araujo AB, O’Donnell AB, Kupelian V, McKnlay JB . A population-level decline in serum testosterone levels in American men. J Clin Endocrinol Metab 92(1): 196-202, 2007 4. Lopez DS, Canfield S, Wang R. Testosterone replacement therapy and the heart: friend, foe or bystander

Open access
The Relation Between Metabolic Syndrome and Testosterone Level

ER, Bloom DA, McGuire EJ. A brief history of testosterone. J Urol 165: 371-73, 2001. 8. Feldman HA, Longcope C, Derby CA et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 87: 589-598, 2002. 9. Brand JS, van der Tweel I, Grobbee DE, Emmelot-Vonk MH, van der Schouw YT . Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observation studies. Int J Epidmiol 40

Open access
Effects of isoflavones on testicular weight and testosterone secretion in ISA Brown roosters

References Akinola O.B., Akinlolu A.A., Adekeye N.A., Oladosu O.S., Dosumu O.O., Olatunji L.A. (2007). Effect of methanol extract of soy on testicular morphometry and plasma testosterone levels. Pak. J. Pathol., 18: 20-24. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoch N., Shibuya M., Fukami Y. (1987). Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem., 262: 5592-5595. Ciereszko R., Opałka M., Kami ńska B., Wojtczak M., Okrasa S., Dusza L. (2001

Open access
Effects of non-linear periodisation training on the explosive force and plasma testosterone

References Andrade N. V. S., R. N. Gonçalves (2008) Uma revisão sobre treinamento concorrente. Ensaios e Ciěncia 12:17-33. Bosco C., J. Tihanyi, A. Viru (1996) Relationships between field fitness test and basal serum testosterone and cortisol levels in soccer players. Clin. Physiol. 16:317-322. Brown L. E., G. E. Bradley-Popovich, G. G. Haff (2001) Non-linear versus linear periodization models. J. Strength Cond. Res. 23:42-44. Brown L., M. Greenwood

Open access
Effect of Testosterone Propionate on Erythropoiesis after Experimental Orchiectomy

References 1. Werner A. The Male Climacteric. JAMA 1939; 112(15):1441-3. 2. Kumanov Ph. The Male Climacteric? Sofi a: AB Studio, 2002 (Bulgarian). 3. Chen H, Zirkin BR. Long-term suppression of Leydig cell steroidogenesis prevents Leydig cell aging. Proc Natl Acad Sci USA 1999;96(26):14877-81. 4. Luo L, Chen H, Zirkin BR. Temporal relationships among testosterone production, steroidogenic acute regulatory protein (StAR), and P450 side-chain cleavage enzyme (P450scc) during Leydig cell

Open access
Immunohistomorphometric Changes of The Pituitary Gonadotropic Cells After Testosterone Application in a Rat Model of the Andropause

, I. (2004). Polymorphisms in androgen and estrogen receptor genes: effects on male aging. Exp Gerontol. 39, 603-611. PMid:15582276 5. Wang, X.J., Stocco, D.M. (2005). The decline in testosterone biosynthesis during male aging: A consequence of multiple alterations. Mol Cell Endocrinol. 238, 1-7. PMid:15939533 6. Bonavera, J.J., Swerdloff, R.S., Leung, A., Lue, Y.H., Baravarian, S., Superlano, L., Sinha-Hikim, A.P., Wang, C. (1997). In the male brown-Norway (BN

Open access
Dynamics of Prostate-Specific Antigen Levels During Treatment with Testosterone Undecanoate in Patients with Type 2 Diabetes Mellitus

. Stanworth RD, Jones TH. Testosterone in obesity, metabolic syndrome and type 2 diabetes. Front Horm Res 37: 74-90, 2009. 8. Stanworth RD, Kapoor D, Channer KS, Jones TH . Statin therapy is associated with lower total but not bioavailable or free testosterone in men with type 2 diabetes. Diabetes Care 32: 541-546, 2009 9. Curran MJ, Bihrle W 3rd . Dramatic rise in prostate-specific antigen after androgen replacement in a hypogonadal man with occult adenocarcinoma of the prostate. Urology 53: 423-424, 1999. 10. Loughlin

Open access
Correlations of Endogenous Testosterone and DHEA-S in Peripheral Arterial Disease

;116:1509-1526. 4. Hak AE, Witteman JCM, De Jong FH et al. Low levels of Endogenous Androgens Increase the Risk of Atherosclerosis in Elderly Men: The Rotterdam Study. The Journal of Clinical Endocrinology & Metabolism. 2002;87(8):3632-3639. 5. Freeman BM, Mountain DJ, Brock TC et al. Low testosterone elevates interleukin family cytokines in a rodent model: a possible mechanism for the potentiation of vascular disease in androgen-deficient males. J Surg Res. 2014;190(1):319-27. 6. Haring R, Travison TG, Bhasin S et al. Relation between sex hormone concentrations

Open access
About Distributed Control in Model of Testosterone Regulation

] CHURILOV, A.—MEDVEDEV, A.—MATTSON, P.: Discrete-time modelling of a hereditary impulsive feedback system . In: IEEE 53rd Annual Conference on Decision and Control—CDC ‘14, Los Angeles, CA, USA, IEEE, 2014, pp. 765–770. [9] SMITH, W. R.: Qualitative mathematical models of endocrine systems , Am. J. Physiol. 245 (1983), 473–477. [10] MURRAY, J. D.: Mathematical Biology: I. An Introduction (3rd ed.), Springer, Berlin, 2001. [11] CARTWRIGHT, M.—HUSAIN, M.: A model for the control of testosterone secretion , J. Theor. Biol. 123 (1986), 239

Open access
Influence of Testosterone Replacement Therapy on Metabolic Disorders in Male Patient with Type 2 Diabetes Mellitus and Androgen Deficiency

, Zitzmann M, Cunningham G. Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes. Diabetes Care. 2011;34(7):1669-75. 5. Oh JY, Barrett CE, Wedick NM, Wingard DL. Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo Study. Diabetes Care. 2002; 25: 55-60. 6. Kapoor D, Malkin CJ, Channer KS, Jones TH. Androgens, insulin resistance and vascular disease in men. Clin Endocrinol. 2005; 63: 239-250. 7. Simon D

Open access